An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Phaze, a popular app for people using GLP-1 drugs like Ozempic, just released an update (v3.1) after three months of listening to users. The update isn’t about flashy new marketing features. It’s a set of practical changes that people kept asking for. The developer collected complaints and suggestions from community forums and direct feedback, then built features to track lab results, body composition, and help with tapering doses. GLP-1 drugs are medications that mimic a natural gut hormone. In plain terms, they help you feel full and slow stomach emptying, which can lower appetite and help with blood sugar control. People use them for type 2 diabetes and, increasingly, for weight loss under a doctor’s care. Phaze is a tracker app meant to help users record doses, symptoms, and progress while using these drugs. The new lab-tracking features let users log and trend medical tests: A1C (a measure of average blood sugar over a few months), cholesterol and other lipids, kidney and liver tests, thyroid function, and vitamin D. You can now import DEXA scans (a precise body composition scan) and watch body fat percentage and lean mass change separately from total weight. There’s also a “taper coach” to help people record and plan gradual dose changes. This is not clinical research — it’s a product change based on user requests. The app doesn’t make medical claims about outcomes; it just gives better ways to store and visualize the data users already get from their doctors and scans. Why this matters to regular people: these additions make it easier to keep a fuller picture of health while on GLP-1 therapy. Weight alone can be misleading; tracking body fat and lean mass shows whether weight loss is mostly fat or muscle. Keeping A1C, liver, kidney, and thyroid numbers in one place helps people and their clinicians spot trends and side effects sooner. The taper coach could be useful for people working with a provider to reduce doses without losing track of changes in symptoms or labs. Caveats and risks: Phaze is a tracker, not a doctor. The app can store and display data, but it can’t diagnose or recommend treatment. Any changes to medication, including tapering, should be done under medical supervision. Imported scans and lab results are only as useful as their source; inconsistent testing or self-diagnosis can be misleading. Also, privacy and data security matter — check how the app handles your medical information. Finally, this update reflects user priorities, not new scientific evidence about GLP-1 drugs themselves. Bottom line: Phaze v3.1 adds lab tracking, DEXA import, and a tapering tool to help users and their clinicians get a clearer, more clinical view of health while using GLP-1 medications.
Source: r/Semaglutide